Amanote Research
Register
Sign In
Orphan Designation: Human Glucagon-Like Peptide-2 Analogue Linked to a Human Immunoglobulin Fc Fragment, Treatment of Short Bowel Syndrome
Case Medical Research
doi 10.31525/cmr-ea7c2a
Full Text
Open PDF
Abstract
Available in
full text
Date
March 27, 2019
Authors
Unknown
Publisher
Case Journals
Related search
Role of Glucagon-Like Peptide–2 Deficiency in Neonatal Short-Bowel Syndrome Using Neonatal Piglets
Pediatric Research
Child Health
Pediatrics
Perinatology
Pharmacological Characterization of Apraglutide a Novel Long-Acting Peptidic Glucagon-Like Peptide-2 Agonist for the Treatment of Short Bowel Syndrome
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
Orphan Designation: Recombinant Human Club Cell 10 KDa Protein, Treatment of Bronchiolitis Obliterans Syndrome
Case Medical Research
Orphan Designation: Dantrolene Sodium, Treatment of Wolfram Syndrome
Case Medical Research
Subfragments From the Fc Fragment of Human Immunoglobulin G. Isolation and Physicochemical Characterization
Biochemical Journal
Elevated Plasma Glucagon-Like Peptide 1 and 2 Concentrations in Ileum-Resected Short Bowel Patients With a Preserved Colon
Gastroenterology
Hepatology
Gastroenterology
Differentiation of Species in Human Beta-Haemolytic Group G Streptococci Using Immunoglobulin Fc Fragment Receptor.
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
A pH-Induced Switch in Human Glucagon-Like Peptide-1 Aggregation Kinetics
Journal of the American Chemical Society
Biochemistry
Colloid
Catalysis
Chemistry
Surface Chemistry
A Biological Function for Glucagon-Like Peptide-2
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
